Accrued Expenses and Restructuring Reserve

12 Months Ended

Dec. 31, 2020

Accrued Expenses and Restructuring Reserve [Abstract]

Accrued Expenses

Note 9 – Accrued Expenses and Restructuring Reserve

Accrued expenses and other liabilities consist of the following:

	December 31,
	2020		2019
Accrued research and development costs	$	204,780	$	16,415
Accrued professional fees		219,822		256,062
Accrued compensation		1,310,720		603,229
Accrued rent		-		221,934
Total	$	1,735,322	$	1,097,640

Restructuring Reserve

Restructuring Reserve

Restructuring reserve relates to the severance costs incurred by Edge Therapeutics in 2019 prior to the merger transaction and assumed by the Company as part of the purchase accounting, but not yet paid. Through September 2020, restructuring costs of $498,185 was paid. As of December 31, 2020, the balance of the restructuring reserve was $0.